Medication Brand Name:

MabCampath

 
Active Ingredient:
alemtuzumab
 
DIN(s) in Canada:
02290960
 
francais
Manufacturer/Distributor:
Genzyme Canada Inc.
 
DrugCoverage Category:
Cancer
 
See Also:


MabCampath ® is an eligible benefit through some private insurance plans, and also through some provincial and federal drug programs. Additionally MabCampath® is also under review for funding in some provinces. A summary of coverage is below. For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.

Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
MabCampath® is an eligible benefit through some private insurance plans. Some plans may require special authorization / prior authorization before granting reimbursement. For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
Alberta AB Under Review MabCampath is currently under review by the provincial drug program.
British Columbia BC Covered MabCampath is covered according to eligibility criteria through the BC Cancer Agency
Manitoba MB Under Review MabCampath is currently under review by the provincial drug program.
New Brunswick NB Under Review MabCampath is currently under review by the provincial drug program.
Newfoundland & Labrador NL Under Review MabCampath is currently under review by the provincial drug program.
Northwest Territories NT Under Review MabCampath is currently under review by the territorial drug program.
Nova Scotia NS Covered MabCampath is covered according to eligibility criteria by Cancer Care Nova Scotia
Nunavut NU Under Review MabCampath is currently under review by the territorial drug program.
Ontario ON Not Covered MabCampath is not currently covered by Cancer Care Ontario/Ontario Drug Benefit (ODB) Program.
Prince Edward Island PE Under Review MabCampath is currently under review by the provincial drug program.
Quebec QC Under Review MabCampath is currently under review by the provincial drug program.
Saskatchewan SK Under Review MabCampath is currently under review by the provincial drug program.
Yukon Territory YT Under Review MabCampath is currently under review by the territorial drug program.
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Possible Coverage MabCampath may be covered by the Public Services Health Care Plan after a medical review.
Non-Insured Health Benefits Under Review MabCampath is currently under review by the NIHB
Veterans Affairs Canada Under Review MabCampath is currently under review by VAC
 
Health Canada Drug Product Database Listing